Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

InfuSystem Holdings (INFU) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for InfuSystem Holdings (INFU) over the last 17 years, with Q3 2025 value amounting to 5.99%.

  • InfuSystem Holdings' EBITDA Margin rose 21700.0% to 5.99% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.78%, marking a year-over-year increase of 32600.0%. This contributed to the annual value of 1.76% for FY2024, which is 13900.0% up from last year.
  • Latest data reveals that InfuSystem Holdings reported EBITDA Margin of 5.99% as of Q3 2025, which was up 21700.0% from 6.79% recorded in Q2 2025.
  • InfuSystem Holdings' EBITDA Margin's 5-year high stood at 6.79% during Q2 2025, with a 5-year trough of 2.83% in Q1 2024.
  • Over the past 5 years, InfuSystem Holdings' median EBITDA Margin value was 2.12% (recorded in 2024), while the average stood at 1.62%.
  • The largest annual percentage gain for InfuSystem Holdings' EBITDA Margin in the last 5 years was 52900bps (2021), contrasted with its biggest fall of -409700bps (2021).
  • Over the past 5 years, InfuSystem Holdings' EBITDA Margin (Quarter) stood at 2.2% in 2021, then crashed by -100bps to 0.01% in 2022, then tumbled by -14237bps to 1.49% in 2023, then skyrocketed by 341bps to 3.59% in 2024, then surged by 67bps to 5.99% in 2025.
  • Its EBITDA Margin was 5.99% in Q3 2025, compared to 6.79% in Q2 2025 and 1.49% in Q1 2025.